⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

March 16, 2017Amyloid

Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival

Eli Muchtar Angela Dispenzieri Shaji Kumar Francis K. Buadi Martha Q. Lacy Steven R. Zeldenrust Suzanne R. Hayman Nelson Leung Taxiarchis Kourelis Wilson I. Gonsalves Rajshekhar Chakraborty Stephen J. Russell David Dingli John A. Lust Yi Lin Prashant Kapoor Ronald S. Go Robert A. Kyle S. Vincent Rajkumar Morie A. Gertz

View at Publisher

Ask AI

Bookmark

Share

Abstract

"Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival." Amyloid, 24(sup1), pp. 40–41

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Muchtar et al. (2017) studied this question.

synapsesocial.com/papers/6ab77c28565d583c72939d21 https://doi.org/10.1080/13506129.2016.1277696

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Multiple musculoskeletal procedures over time and the risk of amyloidosis: a Danish nationwide cohort studyAmyloid · Tue,
2Quality standards for the diagnosis and management of ATTR and AL amyloidosis: a nominal group technique studyAmyloid · Wed,
3Childhood onset, indolent progression, and risk of hepatic rupture: the natural history of hereditary lysozyme amyloidosisAmyloid · Mon,
4Treatment of Waldenström macroglobulinemia associated with AL amyloidosis with teclistamab: a case reportAmyloid · Mon,
5Emerging therapies and translational tools for drug development in systemic amyloidosis: insights from the International Society of Amyloidosis Scientific WorkshopAmyloid · Mon,

More from Amyloid

Cryo-EM reveals untwisted and non-periodic twist fibrils in ex vivo type B ATTRv-V30M fibrilsWed,
Frailty is a mortality risk factor in tafamidis-treated patients with transthyretin cardiac amyloidosisThu,
Liver stiffness in AL amyloidosis: interest in diagnosis and prognosisSun,
Susceptibility and screening approaches in systemic amyloidosis: expert perspectives from the International Society of Amyloidosis (ISA)Fri,
Gastric amyloid pathology and mucosal denervation in ATTRv amyloidosis: insights from patients, mice, and gut microenvironment profilesSat,